ISRCTN58283041已完成不适用
Suppression of breakthrough bleeding in levonorgestrel intrauterine system (Mirena system) users
ational Institute of Child Health and Development (NICHD) (USA)0 个研究点目标入组 150 人开始时间: 2006年12月28日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Healthy female volunteers aged between 19 to 48 years
- •2. Requesting and receiving a LevoNorGestrel IntraUterine System (LNG-IUS) for contraception
- •3. Must have menstrual cycle of 17 to 42 days, lasting not longer than ten days
- •4. Not currently using any form of hormonal treatment
排除标准
- •1. Is less than three months postpartum
- •2. Is less than one month post-lactation
- •3. Has been sterilised
- •4. Abnormal laboratory test finding clinically significant at screening or insertion
- •5. Currently participating in another study
- •6. History of cancer in the five years previously
- •7. History of significant medical disease
- •8. History of significant psychatric illness
- •9. Is currently on corticosteroid therapy
- •10. Unwilling or unsuitable for assessment and follow up
- •11. History of drug/alcohol abuse in past year
- •12. Found to have significant gynaecological disorder
- •13. History of abnormal vaginal bleeding
- •14. Has coagulopathy or on anticoagulation
- •15. Allergy to ingredients
研究者
相似试验
招募中
不适用
Menorrhagia Control with Two Hormonal IUDsMenorrhagiaRBR-97fxm4gCAISM - Centro de Atenção Integral à Saúde da Mulher
已完成
不适用
The effect of labetolol on reducing bleeding during and after functional endoscopic sinus surgery(FESS)Chronic sinusitis.Abscess empyema infection suppuration (chronic) of sinus (accessory)(nasal)IRCT201511295225N6Vice chancellor for research, Tehran University of Medical Science32
招募中
1 期
The Dan-DAPT trialMyocardial infarctionCTIS2022-500125-32-00Rigshospitalet2,700
招募中
不适用
Intraoperative bleeding control with thrombin-gelatin-matrix (Floseal) in advanced gynecologic surgery. A case-control study with special focus on hemostasis in patients with primary or secondary coagulapathies.D62T81.0Acute posthaemorrhagic anaemiaHaemorrhage and haematoma complicating a procedure, not elsewhere classifiedDRKS00004903St. Josefskrankenhaus200
已完成
不适用
O BLEeding excess with antiplatelet treatment with thromboserin during coronary artery bypass grafting (CABG)ISRCTN59071456Imperial College London (UK)120